OPTIMIZATION OF A CLINICALLY VALIDATED CART FLOW ASSAY FOR COMMERCIAL ANTI-CD19 CART T-CELL THERAPY AND UNIVERSAL ASSAYS FOR DETECTION OF NOVEL CAR-T CONSTRUCTS | Publicación